ILIAD BIOTECHNOLOGIES

ILiAD Biotechnologies (ILiAD) is a clinical stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis. Our lead candidate, BPZE1, is the most advanced next generation pertussis vaccine, having completed two Phase 2 clinical trials. ILiAD Biotechnologies, LLC is a registered Delaware company founded in 2012... ILiAD Biotechnologies is a clinical stage biotechnology company dedicated to the prevention and treatment of diseases caused by Bordetella Pertussis. Our lead candidate, BPZE1, represents the most advanced next generation pertussis vaccine, successfully completing two Phase 2 clinical trials. Join us in advancing public health through innovative vaccine solutions... Founded in 2020, BioLyo Technologies, BV is a wholly-owned ILiAD subsidiary based in Ghent, Belgium. BioLyo is a Contract Development Manufacturing Organization (CDMO) focused on process and analytical development for Live Bacterial Products. Link to website.

Also known as: ILiAD